This review aims to focus attention on the bio-oxidative therapy from the very beginning to date. While ultraviolet blood irradiation is now hardly performed, oxygenozone therapy, after an empirical stage, has grown to be precise and safe. Meantime, there is a renewed interest in the infusion of a dilute solution of hydrogen peroxide in infectious diseases antibiotic-resistant.
Introduction
The first idea of using ultraviolet blood irradiation (UBI), also known as biophotonic therapy or photophoresis for exploiting its bactericidal and tissue-stimulating effects on the disfiguring lupus vulgaris was born in the genial mind of Niels Ryberg Finsen (Nobel Prize for Medicine in 1903) [1] . Like all Nordish people, he loved the light and sunshine and he treated his own disease bathing in the sun. Most importantly he was able to successfully promote this therapy in tubercolosis.
In the 1920s, UBI was popularized by Emmet Knott [2] by treating severe infections but it fell out of use after the power of antibiotics and because Schwartz et al [3] judged the procedure too empirical. UBI was and is still partly considered useful for pathogen reduction, increase tissue oxygenation, and induction of antioxidant enzymes as well as activation of the immune system.
Another type of bio-oxidative therapy was proposed by Dr. I.N. Love working in St. Louis (USA) when, in 1888, published a paper entitled "Hydrogen peroxide as a remedial agent" [4] . After almost a century, in 1993 Dr. C.H. Farr promoted the use of intravenous administration of a dilute solution (0.03-0.15%) of H 2 O 2 in several illnesses, but it hardly became known because Werhly and Steinbarth [5] had proposed to collect blood in a special quartz ampoule and to expose it for a short time to UV light in the presence of pure oxygen followed by re-infusion into the donor. This method was a re-edition of UBI and it had been mostly criticized because the ampoule had to be sterilized each time for avoiding the risk of viral crossinfections. Unfortunately, such a drawback has occurred in several occasions [6, 7] . Moreover, UBI remains an uncertain procedure because one never knows the irradiation efficiency due to progressive decay of the UV source and the variable time of irradiation with a possible damage of blood cells.
Luckily, by the 1970's the physicist Joachim Hansler invented a reliable ozone generator for medical use and Hans Wolff [8] realized the need to expose blood to a mixture of oxygen-ozone in a dispensable, ozone-resistant glass bottle. Wolff deserves the credit for having developed the new type of bio-oxidative therapy in the safe form of ozonated autohemotherapy (AHT).
After three decades, the concept of ozone therapy remains valid because the most recent ozone generators incorporate an UV photometer able to precisely monitor the ozone concentration in realtime. However, as it will be discussed later, the correct procedure is not accepted by all ozonetherapists and several pejorative modifications have been introduced. This is not surprising because in the medical field, drugs and methodologies undergo recurrences. While UBI is hardly used, infusion of a diluted solution of H 2 O 2 has come back to light owing to antibiotic resistance and because H 2 O 2 has a milder antioxidant potential of 1.78 V compared to ozone, with E° = +2.07 V. H 2 O 2 is a physiological molecule considered essential for the cell life and also because during the "oxidative burst" is produced for inactivating pathogens [9] .
The actual state of art of ozone therapy It is unpleasantly surprising that in the field of complementary medicine oxygen-ozonetherapy is not even mentioned because it is a recent development but mostly because it has no sponsors. Although the development of this topic has clearly shown to be well within the classical biochemistry and pharmacology, in contraposition to homeopathy, acupuncture, aromatherapy, Ayurveda and Chinese medicine, it remains unknown. On the other hand there is an ample literature and knowledge of ozone toxicity for the pulmonary system. Indeed as ozone has strong oxidizing properties, it seems paradoxical that this gas may display beneficial effects. Although this appears paradoxical, it has been proven true [10] . On the basis of this synthesis: 3O 2 + 68,400 Cal 2O 3 and the fact that the reaction is reversible, it has been shown that ozone readily dissolved in the blood water, releases its energy into hematic components, hence into the body during the reinfusion procedure into the blood donor. Ozone is about ten-fold more soluble in water than oxygen [11, 12] [20] [21] [22] . In other words, when the highest ozone concentration is mixed with blood, depending upon the modest interindividual variability of antioxidant potency (1.28-1.83 mmol/L plasma) [23] the highest H 2 O 2 concentration measured in plasma is 40-50 μM [24] and therefore inside the cells is at most 4-5 μM. This sudden inflow of this small amount of H 2 O 2 inside blood cells is the stimulus necessary to activate a series of biochemical reactions as follows: a) in the erythrocytes: activation of glycolysis with increase of ATP and 2,3-diphosphoglycerate. Functionally, the oxyhemoglobin sigmoid curve shifts to the right and increases the release of oxygen at the tissue level. The erythrocytes mop up most of the H 2 O 2 and promptly reduce it to water by catalase, thioredoxin, glutathione peroxidase (GSH-Px) and reduced glutathione (GSH). The sudden formation of oxidized glutathione (glutathione disulphide; GSSG) alters the GSH/GSSG ratio but the cell quickly correct it by either extruding some glutathione disulphide or by reducing it via GSH reductase at the expense of either ascorbic acid or thioredoxin. This important recycling process occurs in about three minutes [25, 26] , Alternatively, activation of glucose-6-phosphate dehydrogenase (G6PDH) provides reducing power and activates glycolysis.
b) in the leukocytes: neutrophil phagocytic activity is enhanced. Inside monocytes and lymphocytes, H 2 O 2 activates a tyrosin-kinase with consequent phosphorylation of IκB, one of the trimeric components at rest of the nuclear factor kappa-B (NF-κB) [27, 28] . The phosphorylated IκB detaches from the trimer and it is broken down in the proteasome. The remaining heterodimer p50-p65 is transferred into the nucleus where it can activate about 100 genes. Of great significance it is the final release of some cytokines (IFNγ, TNFα and IL-8) and of some acute-phase proteins [10] ; c) in the platelets: in relation to the ozone concentration, we have measured release of PDGF-AB, TGFβ-1 and IL-8 [29] . Growth factors have a specific relevance in enhancing ulcer's healing.
It must be said that the H 2 O 2 concentration in the cells (2-5 μM) is the minimal necessary to switch on cellular responses and it probably lasts few seconds as GSH-Px and catalase promptly reduce it to H 2 O. An ozone concentration below 10 μg/ml gas per ml of blood is most likely totally quenched by the hydrosoluble antioxidants and therefore no biological effects can be elicited and, at the best, the procedure has only a placebo effect. In plasma, the H 2 O 2 half-life is less than 1 minute and it is absent during blood reinfusion. On the other hand, among a variety of lipid oxidation products (LOPs), 4-HNE remains fairly stable. A small part is broken down at once by enzymes such as GSH-Stransferases and aldehyde dehydrogenase [30] but the bulk forms an adduct with the -SH group of Cys34 present in domain-I of albumin. Furthermore, eleven nucleophilic residues (Lys199 and His146) can also bind up eleven 4-HNE molecules. Thus, owing to the high albumin amount (about 125 g intravascular and 160 g extravascular) the bound alkenals undergo a great dilution in the body fluids implying a most important loss of toxicity.
An interesting aspect is that albumin can transfer 4-HNE to ALL body tissues, from liver to endocrine glands and the CNS. Thus 4-HNE-Cys adducts can be released at many sites and inform a variety of cells of a transient, acute oxidative stress. At submicromolar or picomolar levels, 4-HNE can act as a well-known signaling molecule [31] able to activate the synthesis of γ-glutamate cysteine ligase, γ-glutamyl transferase, γ-glutamyl transpeptidase, HSP-70, heme-oxygenase-I (HO-1), and antioxidant enzymes such as superoxide dismutase (SOD), GSH-peroxidase, catalase and, last but not least important, G6PDH, a critical enzyme electron-donor during erythropoiesis in the bone marrow. There is a wide consensus on the relevance of the induction of protective molecules during small but repeated oxidative stress [32] [33] [34] [35] [36] [37] [38] . In other words, the concept that a precisely controlled oxidative stress can strengthen the antioxidant defenses is well accepted today and represents a conditioning or adaptation effect. At the time of ozonated blood infusion, 4-HNE-Cys adduct can also act on the vast expanse of endothelial cells and enhance the production of NO. This crucial mediator on its own or as a nitrosothiol, with trace of CO released with bilirubin via HO-1 activity allows vasodilation, thus improving tissue oxygenation in ischemic tissues. H 2 S is another potentially toxic molecule that, when released in trace amounts, becomes another important physiological mediator like NO and CO [39, 40] .
Another very interesting aspect observed in 67-78 years old subjects affected by the dry form of agerelated macular degeneration (ARMD) is that a majority of them report a feeling of euphoria and a sense of wellness and physical energy throughout the ozonetherapy cycle of 14-16 treatments lasting about two months [41] . Whether these feelings are simply due to faith in the medical treatment (the power of the mind!), i.e. the power of the placebo effect [42] or is caused by the generated ozone messengers able to modify or improve the hormonal secretion is not yet known. Unfortunately, lack of funds has always prevented to perform a study in normal volunteers where, before and after ozonetherapy, the complete hormonal pattern and cycling in the plasma throughout the 24 hours could have been determined. This study would be very informative and helpful to understand why the patients experiment a feeling of well-being. This may be due to improved oxygenation or/and enhanced secretion of human growth hormone, cortisol, and dehydroepiandrosterone. Patients with arthrosis pain have also reported a marked improvement and less pain that may be due to release of ACTHcortisol or to a limited stimulation of COX-2 with enhanced release of prostacyclin (PGI 2 ). It is also possible that LOPs reaching the hypothalamic area improve the release of neurotransmitters such as serotonin. dopamine, and endorphins as it has been observed after an intense physical exercise [43] [44] [45] .
It is important to note that neither acute nor chronic toxicity has been ever observed during or after ozone therapy. Several studies [17, 19, 46] performed to evaluate possible hematochemical biochemical enzymatic modifications have clearly demonstrated that ozone concentrations of 20-80 (even up 160) μg/ml of gas per ml of blood do not damage blood cells or other components. Indeed during the ozonation process no more than 35% of the total antioxidant capacity is oxidized and it is noteworthy that is reconstituted during the next twenty minutes in vitro and in a shorter time in vivo [47] .
Is it possible that ozone can oxidize the phospholipids and cholesterol of the cell membrane? The demonstration that the negative electric charge of the erythrocytic membrane is unmodified even after ozonation at 80 μg/ml ozone per ml of blood excludes this possibility. It is well known that blood cell membranes are always shielded by a cloud of albumin molecules able to prevent any ozone attack that it has been suggested by some authors, who claim to have noticed an increased flexibility (or an enhanced filterability) of erythrocytes after ozonation. These sort of claims have been mentioned before during UBI and, if correct, may have been due to excessive irradiation and oxidation or may well have happened during ozonation of saline-washed erythrocytes [48] . Unfortunately too many artificial experiments performed with saline-washed cells totally deprived of the plasmatic antioxidants have led to wrong conclusions [49] . Moreover the validity of an objective biochemical analysis carried out last century on UBI by practitioners remains doubtful.
A brief comment regarding the efficacy and safety of administration procedures
Of the several procedures currently used for ozone administration on the basis of previous data it is suggested to use either the classical major ozonated autohemotherapy [14] or the quasi-total body exposure to oxygen-ozone (QTBE) [50] . This second approach is very appealing because with the ozonetherapist's guidance can be done at home at any time. With the exception of the neck and head (to absolutely prevent ozone inhalation) all the remaining body surface (about 1.4-1.5 m 2 ) becomes in contact with a final concentration of 0.5-0.9 µg/ml within a tightly closed ozone resistant cabinet where the temperature via a thermostat can be regulated between 30-42°C and 100% relative humidity. This ozone concentration is about 30-fold lower than the one used in the topical treatment of skin ulcers [51] . The subject is comfortably seated inside almost nude and with her/his wet skin surface. This is important because ozone immediately reacts with sweat and lipids normally secreted by sebaceous glands. The skin tolerates well ozone at environmentally realistic level, while it is fairly sensitive to higher levels [52] [53] [54] [55] . The QTBE has also the advantage to avoid venipuncture that is sometimes difficult to perform in women.
The extracorporeal blood ozonation within an ozone-resistant gas exchange device has limited value because it is invasive (two venipuncture with G16 needles), more complex and expensive. It can be used only in patients at the risk of either amputation or after a stroke or a heart infarction. On the other hand the rectal insufflation of gas is easy to perform, practically risk-free but it is unreliable because the effective ozone dose acting on the luminal content remains uncertain. Moreover in Europe not all patients accept this procedure.
Which are the pathologies more suitable to be treated with ozonetherapy?
Clinical results so far available have been objectively discussed elsewhere [14] showing that ozonetherapy is often more useful than orthodox treatments in a first category of diseases such as: a) osteomyelitis, pleural empyema, abscesses with fistulae, infected wounds, bed sores, chronic ulcers, diabetic foot and burns. b) advanced ischaemic diseases (hind-limb ischemia and heart ischemia, possibly also stroke, when the patients arrive too late for thrombolysis).
c) age-related macular degeneration (atrophic form) because ortodox ophthalmology does not provide a meaningful treatment.
d) orthopaedic diseases and localized osteoarthrosis.
e) chronic fatigue syndrome and fibromyalgia. f) dentistry regarding primary root carious lesions, particularly in children. g) stomatology for chronic or recurrent infections in the oral cavity.
For these pathologies ozone is a real "wonder" drug.
In a second category of diseases including: a) acute and chronic infectious diseases, particularly due to antibiotic or chemoresistant bacteria, virus and fungi (hepatitis, HIV-AIDS, herpetic infections and herpes zoster, papillomavirus infections, onychomycosis and candidiasis, giardiasis and cryptosporidiosis) ozonetherapy represent only a useful support because neither ozone, nor H 2 O 2 reach the concentration where free pathogens are protected by plasma antioxidants [56] . Intracellular viruses are inaccessible b) cancer-related fatigue, ozone therapy, associated with orthodox treatments, may accelerate and improve the outcome. However so far ozonetherapy has been unable to "cure" cancer.
There is a third category of serious diseases such as: a) autoimmune diseases (multiple sclerosis, rheumatoid arthritis, crohn's disease, psoriasis). b) senile dementias. c) pulmonary diseases (emphysema, asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and acute respiratory distress syndrome).
d) skin diseases (psoriasis and atopic dermatitis). e) metastatic cancer. f) severe sepsis and multiple organ dysfunction, where the combination of orthodox treatments and ozone therapy, at least on theoretical ground, may be helpful but real clinical evidence is lacking. Anecdotal data are encouraging but in most cases achieved by using several types of therapy.
Whether ozone therapy with the advantages of low cost and no adverse effects, may equal the efficacy of current conventional treatments remains to be explored. However, how and when will we be able to perform these investigations standing the actual situation of total disinterest of health authorities, lack of specific sponsors and the overwhelming power of pharmaceutical industries, which are only interested in pursuing their objectives. Ironically, it is possible that less developed countries with minimal budgets may have an interest in performing pilot trials that can give us precious informations regarding the usefulness of ozone therapy.
A fourth category of diseases such as retinitis pigmentosa, sudden hearing loss and tinnitus where ozone therapy does not yield real therapeutic results must be mentioned. However when ozonetherapy is applied for compassionate reasons, especially in young patients or patients in the acute phase, may yield some benefit that, even temporary, helps anguished patients.
In Table 1 tentative guidelines regarding ozone concentrations within the therapeutic window to be used in different pathologies with the classical ozonated AHT, at least twice weekly are reported. Ozone concentrations are slowly upgraded no more than 5 µg/ml at a time, to achieve the adaptation to oxidative stress in 2-3 weeks. The examination of the table indicates that: firstly, the idea "more is better" is not always appropriate for ozone and its concentration must be calibrated in relation to the effector and target cells;
secondly, the frequency of treatment depends on the type and stage of the disease: from daily to two per week, until necessary and thirdly, the urgent need of further clinical experimentation with appropriate controls to generate definitive clinical data.
Clinical trials are demanding enterprises that require a concerted effort by official medicine and government authorities because the permission of ethical committees is indispensable. A simple but valid randomized study in 100 patients with a control arm (50) using the best orthodox therapy and the experimental arm (50) using wellperformed ozone therapy plus the basic therapy even if it is not too expensive, still requires about € 150.000 for covering insurance, hospital fees, materials and laboratory plus clinical exams. National Health authorities, which are always complaining about the increasing costs of medical assistance, could have an economical advantage if ozonetherapy was widespread and organized in a systematic way in all public hospitals. Although hard data to support this contention are not available, it is likely that the benefit of ozone therapy does outweigh its cost, particularly for the above mentioned first category of diseases. In a public hospital, as an example, ten nurses, under the supervision of an ozonetherapist could easily perform the therapy in about 15 patients per hour. As things are today, it is depressing to realize that ozone therapy will not be applied in public hospitals for years to come, thus depriving many patients of the possibility of restoring their health. On the other hand, some Countries have so many patients and so few resources for treating them that physicians are apparently forced to use procedures such as the infusion of ozonated saline or indiscriminately the rectal insufflation to everyone. This is a very poor compromise because it hinders a real medical progress.
May oxygen ozonetherapy have a future in medicine?
This is an awkward question that needs an objective discussion because all ozonetherapists must understand that ozonetherapy is objected and whenever possible obstructed. Moreover in most countries there are three or more ozonetherapy associations fighting for supremacy. This is simply ridiculous and inadmissible because simply due to either a different medical speciality or petty commercial interests relative to ozone generators and ancillary materials. This disunity prevents pursuing the fundamental interest of performing valid clinical trials, which are essential for progress. Unless we are able to provide convincing evidence that ozonetherapy is not a panacea but it is useful in some diseases, ozonetherapy will remain in limbo.
In countries with small resources such as Cuba and surprisingly in the Russian Federation, it has been established to use in all patients either the rectal insufflation or the infusion of ozonated saline, respectively. They have presented clinical results such as the "cure in diabetic patients with only twenty daily treatments (10 mg daily for twenty sessions) or excellent results in all diseases with the infusion of few bottles of ozonated saline. This ozonated saline solution, although cheap and quick to deliver, at low ozone concentrations acts as a placebo or it can be toxic. Foksinski et al. [57] , after the infusion of 500 ml of ozonated saline, detected 8-oxodeoxyguanosine, a typical oxidative DNA marker, in lymphocytes of atherosclerotic patients. If this was not enough there are some physicians still delivering the gas mixture intravenously with the risk of oxygen embolism and patient's death. Other ozonetherapists, for stinginess, use potentially toxic plastic bags instead of the safe, ozone-resistant glass bottles. Any time this happens ozone therapy loses any possibility to be seriously considered.
Official medicine that is not also free of mishaps owing to the urgency of recovering money spent by big pharmaceuticals, follows the rule of the Helsinki regulations and often achieves valid clinical results.
On this basis, the danger of jeopardizing ozone therapy is high and all ozonetherapists must understand this risk and try to follow only wellestablished guidelines.
Concluding remarks
Various types of bio-oxidative therapy have been proposed but today the classical ozone therapy or/and infusion of a dilute solution of hydrogen peroxide appear the safest and useful provided that they are correctly performed. All ozonetherapists must now realize that the future of these procedures depends upon the demonstration achieved by valid clinical trials that they are efficacious and without side-effects. Ineffective compromises will hinder for ever the acceptance of bio-oxidative therapy by official medicine.
